# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-015083
Filing Date
2017-03-16
Accepted
2017-03-16 16:08:15
Documents
80
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | v461290_10k.htm | 10-K | 1061557
2 | EXHIBIT 23.1 | v461290_ex23-1.htm | EX-23.1 | 2536
3 | EXHIBIT 31.1 | v461290_ex31-1.htm | EX-31.1 | 9477
4 | EXHIBIT 31.2 | v461290_ex31-2.htm | EX-31.2 | 9369
5 | EXHIBIT 32.1 | v461290_ex32-1.htm | EX-32.1 | 3731
6 | EXHIBIT 32.2 | v461290_ex32-2.htm | EX-32.2 | 3935
7 | GRAPHIC | pg02img01_10k.jpg | GRAPHIC | 4345
8 | GRAPHIC | pg13img1_10k.jpg | GRAPHIC | 103256
9 | GRAPHIC | pg14img1_10k.jpg | GRAPHIC | 93316
10 | GRAPHIC | pg15img1_10k.jpg | GRAPHIC | 30192
11 | GRAPHIC | pg54img1_10k.jpg | GRAPHIC | 52323
12 | GRAPHIC | pg6img1_10k.jpg | GRAPHIC | 109690
| Complete submission text file | 0001144204-17-015083.txt |  | 6894351

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL INSTANCE DOCUMENT | plx-20161231.xml | EX-101.INS | 1467122
14 | XBRL TAXONOMY EXTENSION SCHEMA | plx-20161231.xsd | EX-101.SCH | 56002
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | plx-20161231_cal.xml | EX-101.CAL | 54411
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | plx-20161231_def.xml | EX-101.DEF | 312850
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | plx-20161231_lab.xml | EX-101.LAB | 417194
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | plx-20161231_pre.xml | EX-101.PRE | 374987

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 17694548
SIC: 2836 Biological Products, (No Diagnostic Substances)